Pages that link to "Q43149143"
Jump to navigation
Jump to search
The following pages link to Tiotropium as a first maintenance drug in COPD: secondary analysis of the UPLIFT trial (Q43149143):
Displaying 50 items.
- Tiotropium versus placebo for chronic obstructive pulmonary disease (Q24194833) (← links)
- Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysis (Q24197853) (← links)
- Tiotropium versus placebo for chronic obstructive pulmonary disease (Q24202175) (← links)
- Effect of tiotropium on COPD exacerbations: A systematic review (Q26750751) (← links)
- Improving physical activity in COPD: towards a new paradigm (Q26865461) (← links)
- Optimizing management of chronic obstructive pulmonary disease in the upcoming decade (Q27693341) (← links)
- Chronic obstructive pulmonary disease (Q28259151) (← links)
- A novel model-based approach for dose determination of glycopyrronium bromide in COPD (Q34502782) (← links)
- Changing patterns in long-acting bronchodilator trials in chronic obstructive pulmonary disease (Q34554816) (← links)
- Assessing the Impact of Tiotropium on Lung Function and Physical Activity in GOLD Stage II COPD Patients who are Naïve to Maintenance Respiratory Therapy: A Study Protocol (Q34807437) (← links)
- Annual rates of change in pre- vs. post-bronchodilator FEV1 and FVC over 4 years in moderate to very severe COPD (Q34823949) (← links)
- Questionnaire on switching from the tiotropium HandiHaler to the Respimat inhaler in patients with chronic obstructive pulmonary disease: changes in handling and preferences immediately and several years after the switch (Q34944616) (← links)
- Early impact of treatment with tiotropium, long-acting anticholinergic preparation, in patients with COPD - real-life experience from an observational study (Q35208787) (← links)
- Tiotropium in patients with moderate COPD naive to maintenance therapy: a randomised placebo-controlled trial (Q35215919) (← links)
- Adverse health consequences in COPD patients with rapid decline in FEV1 - evidence from the UPLIFT trial (Q35305509) (← links)
- Tiotropium and olodaterol fixed-dose combination versus mono-components in COPD (GOLD 2-4). (Q35344118) (← links)
- Differential changes in quality of life components over 5 years in chronic obstructive pulmonary disease patients. (Q35460352) (← links)
- An Internet-Mediated Pedometer-Based Program Improves Health-Related Quality-of-Life Domains and Daily Step Counts in COPD: A Randomized Controlled Trial. (Q35825580) (← links)
- Safety and efficacy of tiotropium Respimat versus HandiHaler in patients naive to treatment with inhaled anticholinergics: a post hoc analysis of the TIOSPIR trial (Q36251424) (← links)
- Emergency Hospital Care for Exacerbation of COPD: Is Inhaled Maintenance Therapy Modified? (Q36652471) (← links)
- Indacaterol: a comprehensive review (Q37057061) (← links)
- Dissecting asthma pathogenesis through study of patterns of cellular traffic indicative of molecular switches operative in inflammation (Q37122082) (← links)
- Association between depression and maintenance medication adherence among Medicare beneficiaries with chronic obstructive pulmonary disease (Q37230812) (← links)
- SOSPES: SPIRIVA® observational study measuring SGRQ score in routine medical practice in Central and Eastern Europe (Q37249775) (← links)
- The impact of COPD on health status: findings from the BOLD study (Q37351376) (← links)
- Assessing Short-term Deterioration in Maintenance-naïve Patients with COPD Receiving Umeclidinium/Vilanterol and Tiotropium: A Pooled Analysis of Three Randomized Trials (Q37447593) (← links)
- Early intervention with tiotropium in Chinese patients with GOLD stages I-II chronic obstructive pulmonary disease (Tie-COPD): study protocol for a multicentre, double-blinded, randomised, controlled trial (Q37598054) (← links)
- The Saudi Guidelines for the Diagnosis and Management of COPD. (Q37733309) (← links)
- Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agents (Q37804908) (← links)
- NVA237, a long-acting muscarinic antagonist, as an emerging therapy for chronic obstructive pulmonary disease (Q37867838) (← links)
- Chronic Obstructive Pulmonary Disease Megatrials: Taking the Results into Office Practice (Q37867931) (← links)
- Chronic obstructive pulmonary disease: patho-physiology, current methods of treatment and the potential for simvastatin in disease management (Q37880077) (← links)
- Controversies in treatment of chronic obstructive pulmonary disease (Q37930206) (← links)
- Tiotropium bromide inhalation powder: a review of its use in the management of chronic obstructive pulmonary disease (Q37973132) (← links)
- Modifying the course of chronic obstructive pulmonary disease: looking beyond the FEV1. (Q38041635) (← links)
- COPD: early diagnosis and treatment to slow disease progression. (Q38264345) (← links)
- Comparative efficacy of fixed-dose combinations of long-acting muscarinic antagonists and long-acting β2-agonists: a systematic review and network meta-analysis (Q38690660) (← links)
- UPLIFT study - understanding potential long-term impacts on function with tiotropium - and sub-analyses. Bibliographic resume of the obtained results (Q38833734) (← links)
- Chronic Obstructive Pulmonary Disease Individualized Therapy: Tailored Approach to Symptom Management (Q39040871) (← links)
- Future of fixed-dose longacting β2-agonist and antimuscarinic combination therapy in COPD. (Q39298350) (← links)
- Fluticasone Furoate, Vilanterol and Lung Function Decline in Patients with Moderate COPD and Heightened Cardiovascular Risk. (Q40122431) (← links)
- Inhaled treatment of COPD: a Delphi consensus statement (Q42227819) (← links)
- The Impact of Tiotropium on Mortality and Exacerbations When Added to Inhaled Corticosteroids and Long-Acting β-Agonist Therapy in COPD (Q44211280) (← links)
- Survey to determine the efficacy and safety of guideline-based pharmacological therapy for chronic obstructive pulmonary disease patients not previously receiving maintenance treatment (Q47984941) (← links)
- Efficacy of tiotropium in COPD patients from Asia: A subgroup analysis from the UPLIFT trial (Q48679924) (← links)
- Exacerbation recovery patterns in newly diagnosed or maintenance treatment-naïve patients with COPD: secondary analyses of TICARI 1 trial data. (Q55003635) (← links)
- What have we learned from observational studies and clinical trials of mild to moderate COPD? (Q57777296) (← links)
- Comparative study on the efficacy of tiotropium bromide inhalation and oral doxofylline treatment of moderate to severe stable chronic obstructive pulmonary disease (Q82261727) (← links)
- An Evaluation Of Single And Dual Long-Acting Bronchodilator Therapy As Effective Interventions In Maintenance Therapy-Naïve Patients With COPD (Q91892861) (← links)
- Tiotropium in chronic obstructive pulmonary disease - a review of clinical development (Q98163525) (← links)